Sichuan Biokin Pharmaceutical Enrolls First Patient for Lung Cancer Trial; Shares Down 4%

9 months ago 57

Sichuan Biokin Pharmaceutical said the first patient was enrolled in its phase three trial for BL-B01D1, according to a Monday filing with the Shanghai bourse. BL-B01D1 is a dual antibody-drug...

1. Homepage
2. Lung Cancer
3. Sichuan Biokin Pharmaceutical Enrolls First Patient for Lung Cancer Trial; Shares Down 4%